Previous close | 0.2000 |
Open | 0.2100 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 0.2000 - 0.2200 |
52-week range | 0.1447 - 0.2676 |
Volume | |
Avg. volume | 26,492 |
Market cap | 18.369M |
Beta (5Y monthly) | 2.11 |
PE ratio (TTM) | 4.40 |
EPS (TTM) | 0.0500 |
Earnings date | 15 Nov 2023 - 20 Nov 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Vext Science, Inc. ("Vext" or the "Company") (CSE: VEXT) (OTCQX: VEXTF) a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation and marketing to build a profitable multi-state footprint, announces that shareholders voted in favour of all matters included in the Company's information circular for its Annual General Meeting of Shareholders held on December 15, 2022 in Vancouver, British Columbia (the "Meeting").
Vext Science, Inc. ("Vext" or the "Company") (CSE: VEXT) (OTCQX: VEXTF) a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation and marketing to build a profitable multi-state footprint, today announced that it has entered into definitive agreements (the "Purchase Agreements") to acquire Appalachian Pharm Processing, LLC, an Ohio limited liability company, together with its subsidiaries and affiliated companies (collectively, "APP") fo
Vext Science, Inc. ("VEXT" or the "Company") (OTCQX: VEXTF) (CSE: VEXT) a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation, and marketing to build a profitable multi-state footprint, today reported its financial results for the period ended September 30, 2022. All currency references used in this news release are in U.S. currency unless otherwise noted.